EP3400246
METHODS OF TREATING CEA-POSITIVE CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND ANTI-CEA/ANTI-CD3 BISPECIFIC ANTIBODIES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.1.2017EP published:
21.10.2020EP application number:
17700491.8
EPO information:
European Patent Register
Max expiry date:
4.1.2037
Title:
METHODS OF TREATING CEA-POSITIVE CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND ANTI-CEA/ANTI-CD3 BISPECIFIC ANTIBODIES
Timeline
Today
5.1.2017EP application
21.10.2020EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
BACAC, MarinaAddress:
8952 Schlieren, CH
Name:
COLOMBETTI, SaraAddress:
8952 Schlieren, CH
Name:
KLEIN, ChristianAddress:
8952 Schlieren, CH
Name:
SAM, JohannesAddress:
8952 Schlieren, CH
Name:
SARO, JoseAddress:
8952 Schlieren, CH
Name:
UMAÑA, PabloAddress:
8952 Schlieren, CH
Priority
Number:
16150506Date:
8.1.2016Country:
EP
Classification
Categories:
C07K 16/30, C07K 16/28, A61P 35/00